medigraphic.com

2020, Number 1

<< Back Next >>

Rev Mex Anest 2020; 43 (1)

Sedoanalgesia in neonate based on remifentanyl. In relation to a case for epiglottopexy

Madriz‑Godoy MM, Sánchez‑Hernández E, Ortiz‑Hernández EG

Language: Spanish
References: 20
Page: 64-68
PDF size: 205.95 Kb.


ABSTRACT

The neonatal stage comprises from the first day of birth until day 28 of life. It is characterized by being a stage of anatomical, physiological and metabolic immaturity. Due to these characteristics of neonates, anesthetic drugs have an important impact on their respiratory and cardiovascular physiology, and their immaturity on pharmacokinetics. Laryngomalacia is one of the main causes of stridor in this stage, which depending on its severity could require surgical treatment, such as an epiglotopexy. This procedure requires potent analgesia and at the same time the possibility of maintaining spontaneous ventilation for its appropriate evaluation. This can be achieved with the use of remifentanyl. We present the clinical case of a term neonate of 22 days of age who we administered Remifentanyl as the basis of sedoanalgesia for the successful completion of an epiglotopexy. Its analgesic potency, ability to maintain ventilatory automatism and predictable pharmacokinetics in the neonate, makes it an ideal agent to provide adecuate sedoanalgesia for different procedures with an easy titration profile and rapid recovery in the neonate.


REFERENCES

  1. Davis R, Mychaliska G. Neonatal pulmonary physiology. Semin Pediatr Surg. 2013;22:179-184.

  2. Neumann RP, Von Ungern-Sternberg BS. The neonatal lung-Physiology and ventilation. Paediatr Anaesth. 2014;24:10-21.

  3. Dobbie AM, White DR. Laryngomalacia. Pediatr Clin North Am. 2013;60:893-902.

  4. Colaianni C, Bowe S, Osborn H, Lin D, Richmon J, Hartnick C. Robotic epiglottopexy for severe epiglottic prolapse limiting decannulation. Int J Pediatr Otorhinolaryngol. 2017;102:157-159.

  5. Allegaert K, Van den Anker J. Neonatal pain management: still in search of the holy grail. Int J Clin Pharmacol Ther. 2016;54:514-523.

  6. Martin-Lynn D. The basic principies of anesthesia for the neonate. Rev Colomb Anestesiol. 2017;45:54-61.

  7. Kamata M, Tobias J. Remifentanyl: application in neonates. J Anesth. 2016;30:449-460.

  8. Hernández-Gutiérrez D, Sánchez-Hernández E, Ramírez-Aldana L, García-Arreola DAP. Remifentanyl en pediatría. Diferentes escenarios de aplicación. Rev Mex Anest. 2012;35:168-171.

  9. Werner J, Lippert B, Dunne A, Ankermann T, Folz B, Seyberth H. Epiglottopexy for the treatment of severa laryngomalacia. Eur Arch Otorhinolaryngol. 2002;259:459-464.

  10. Oomen K, Modi V. Epiglottopexy with and without lingual tonsillectomy. Laryngoscope. 2014;124:1019-1022.

  11. Reinoso F, Castro L. Influencia de la edad pediátrica en la técnica de anestesia basada en la analgesia con remifentanilo. Rev Esp Anestesiol Reanim. 2004;51:12-19.

  12. Rothstein P. Remifentanyl for neonates and infants: piano, piano con calma. Anesth Analg. 2001;93:1370-1372.

  13. American Heart Association. Soporte vital avanzado pediátrico libro del proveedor. EUA; 2017.

  14. Bang SR. Neonatal anesthesia: how we manage our most vulnerable patients. Korean J Anesthesiol. 2015;68:434-441.

  15. FDA. U.S. Food & Drug Administration. [Online]. Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20630se5-005_ultiva_lbl.pdf.

  16. Wee LH, Moriarty A, Cranston A, Bagshaw O. Remifentanil infusion for major abdominal surgery in small infants. Paediatr Anaesth. 1999;9:415-418.

  17. Kessler P, Ahrens P, Lischke V, et al. Einsatz von Remifentanyl bei Neugeborenen und Sauglingen. Anaesthesiologie und Intensivmedizin. 1999;40:Abstractband DAK 99.

  18. Davis PJ, Galinkin J, McGowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. I. Emergence and recovery profiles. Anesth Analg. 2001;93:1380-1386, table of contents.

  19. Barker N, Lim J, Amari E, Malherbe S, Ansermino JM. Relationship between age and spontaneous ventilation during intravenous anesthesia in children. Pediatr Anesth. 2007;17:948-955.

  20. Sammartino M, Garra R, Sbaraglia F, De Riso M, Continolo N. Remifentanyl in children. Paediatr Anaesth. 2010;20:246-255.




2020     |     www.medigraphic.com